Skip to content
OpenCapital
Get started

Amphastar Pharmaceuticals AMPH Pharmaceutical Products — Revenue

Similar metrics at other companies

Kiniksa Pharmaceuticals International, plc logo
KNSAPharmaceutical — Revenue
$214.27M+55.5%
HWK
HWKNPharmaceutical — Revenue
$8.32M+15.1%
Bausch Health Companies logo
BHCProduct sales — Revenue
$2.5B+12.3%
Pfizer logo
PFEProduct — Revenue
$11.72B+3.7%
Vertex Pharmaceuticals logo
VRTXPharmaceuticals — Product revenues, net
$2.99B+7.8%
Regeneron Pharmaceuticals logo
REGNProduct — Revenue
$1.53B+8.4%

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M—
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$926.83M-19.9%
Enterprise value$1.44B-11.4%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%—
Debt / equity0.2×—
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's pharmaceutical products — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's pharmaceutical products — revenue?
Amphastar Pharmaceuticals (AMPH) reported pharmaceutical products — revenue of $171.17M in Q1 2026.
How has Amphastar Pharmaceuticals's pharmaceutical products — revenue changed year-over-year?
Amphastar Pharmaceuticals's pharmaceutical products — revenue increased by 0.4% year-over-year, from $170.53M to $171.17M.
What does pharmaceutical products — revenue mean?
This metric measures the total gross income generated from the sale of pharmaceutical products within the specified business segment. It reflects the market demand for the company's injectable, inhalation, and intranasal product portfolio. Growth in this figure is a primary indicator of commercial success and market penetration.